NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 937 filers reported holding NOVARTIS A G in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $57,777,000 | +210.4% | 673 | +201.8% | 0.01% | +150.0% |
Q2 2017 | $18,614,000 | +12.4% | 223 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $16,562,000 | -8.3% | 223 | -10.1% | 0.00% | 0.0% |
Q4 2016 | $18,064,000 | -99.4% | 248 | -99.3% | 0.00% | -99.5% |
Q2 2016 | $3,074,323,000 | +13.0% | 37,260 | -0.8% | 0.39% | +5.7% |
Q1 2016 | $2,720,919,000 | -35.2% | 37,561 | -23.0% | 0.37% | -38.8% |
Q4 2015 | $4,197,720,000 | +30.4% | 48,788 | +42.6% | 0.60% | -11.6% |
Q3 2015 | $3,219,623,000 | +10.6% | 34,204 | +6.4% | 0.68% | +4.5% |
Q2 2015 | $2,911,173,000 | -29.7% | 32,157 | -23.4% | 0.65% | -4.7% |
Q1 2015 | $4,138,662,000 | +76.8% | 41,970 | +66.1% | 0.68% | -9.9% |
Q4 2014 | $2,341,518,000 | -27.3% | 25,270 | -26.1% | 0.76% | +18.3% |
Q3 2014 | $3,219,623,000 | +69.5% | 34,204 | +63.1% | 0.64% | -14.7% |
Q2 2014 | $1,899,048,000 | +32.3% | 20,977 | +24.3% | 0.75% | -10.6% |
Q1 2014 | $1,435,308,000 | +76.8% | 16,882 | +67.2% | 0.84% | +12.3% |
Q4 2013 | $811,677,000 | – | 10,098 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |